4 completed. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
Follow Hemoptysis: new trials by email Literature Review of Hemoptysis trials Research Report on Hemoptysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tranexamic Acid : Nebulization vs IV Route for Hemoptysis Tranexamic Acid (TXA) - Hemoptysis, NEBULIZATION | Phase 2 / Phase 3 | Completed | University of Health Sciences Lahore | 172 | 2025-08-01 | 2025-11-28 |
| ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial. Tranexamic Acid 500 MG, Terlipressin, Placebo - Hemoptysis | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 315 | 2022-03-27 | 2026-04-23 |
| Prophylactic Topical Epinephrine to Reduce Bleeding in Transbronchial Lung Biopsies Topical epinephrine, Placebos - Lung Transplant; Complications, Mechanical, Lung Transplant; Complications | Phase 2 / Phase 3 | Completed | University of Maryland, Baltimore | 66 | 2017-07-01 | 2024-08-28 |
| Efficacy of Tranexamic Acid in Hemoptysis Tranexamic Acid, Placebo - Hemoptysis | Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 66 | 2011-01-01 | 2016-05-24 |
Hemorrhage (1)
Lung Diseases (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Respiratory Tract Diseases (4) · Signs and Symptoms (4) · Signs and Symptoms, Respiratory (4) · Hemorrhage (3)
Tranexamic Acid (3) · Epinephrine (1) · Terlipressin (1)
Assistance Publique - Hôpitaux de Paris (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · University of Health Sciences Lahore (1) · University of Maryland, Baltimore (1)
France (1) · India (1) · Pakistan (1) · United States (1)
Benjamin Planquette, MD, PhD (1) · Robert M Reed, MD (1)